Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1444 of 5804
-
Could a magnetic helmet boost memory in Alzheimer's?
Symptom relief Recruiting nowThe study tests the effect of the ATNC MDD-V1 on Alzheimer patients' cognitive function. The ATNC MDD-V1 uses non-invasive stimulation of both magnetic and cognitive training.
Phase: NA • Sponsor: Advanced Technology & Communications • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New drug batoclimab shows promise for Hard-to-Treat Graves' disease
Disease control CompletedThe purpose of this study is to assess the efficacy and safety of 24 weeks of treatment with batoclimab in adult participants with biochemically documented hyperthyroidism due to GD who have failed to achieve euthyroidism on antithyroid drugs (ATDs).
Phase: PHASE2 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New pill could slow Parkinson's progression in early stages
Disease control CompletedThis study investigates the safety and tolerability of drug IkT-148009 in untreated Parkinson's disease volunteers (30 to 80 years old). It also looks at the pharmacokinetics of IkT-148009 in the body and evaluates the effect of IkT-148009 on motor and non-motor features of the d…
Phase: PHASE2 • Sponsor: ABLi Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New Colon-Sparing surgery could improve cancer outcomes
Disease control Recruiting nowThe goal of this clinical trial is to compare the long-term outcomes of Laparoscopic Ileocecal-Sparing Right Hemicolectomy(LISH) compared to traditional laparoscopic right hemicolectomy(TRH) in the treatment of hepatic flexure colon cancer and proximal transverse colon cancer.
Phase: NA • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New radiation method aims to cut side effects in prostate cancer treatment
Disease control OngoingThis single arm trial will investigate a novel way to plan and deliver SABR for prostate cancer. Prostate-directed SABR will be high-dose SABR (40 Gy in 5 fractions) with central sparing of the urethra and peripheral sparing of the rectum and pudendal arteries (SUPR-SABR). This s…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New asthma combo pill for kids shows promise in Late-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate the superiority in terms of efficacy and evaluate the safety of QMF149 (indacaterol (acetate) / mometasone (furoate)) compared to budesonide in children from 6 to less than 12 years of age with asthma. * The study duration will be up to 3…
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New brain stent aims to stop strokes in High-Risk patients
Disease control Recruiting nowThe purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.
Phase: NA • Sponsor: Ton-Bridge Medical Tech. Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control CompletedThis is a multi-center, randomized, double blind, placebo-controlled phase 2 study to evaluate the efficacy, safety, PK and PD ofLW402 in patients with moderate-to-severe atopic dermatitis.
Phase: PHASE2 • Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Anal cancer patients may avoid groin radiation side effects
Disease control Recruiting nowThe purpose of this study is to see whether avoiding preventative radiation to the groin in patients with normal sentinel node biopsy and PET-CT, is at least as effective treating cancer as giving preventative radiation to the groin for patients with anal canal cancer. The inves…
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a fitness tracker help smokers kick the habit for good?
Disease control CompletedGiven the high prevalence of deaths per year attributable to tobacco use, improving smoking cessation treatments is an important public health priority Worldwide. It is also known that practicing physical activity (PA) may help with smoking cessation. Physical activity trackers (…
Phase: NA • Sponsor: University of Oviedo • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a $10 cholesterol pill prevent liver cancer?
Disease control Recruiting nowProspective randomized, multi-center, double blind placebo-controlled trial to assess the chemopreventive impact of atorvastatin (20 mg oral) vs placebo in up to 60 adults with advanced fibrosis at high risk of developing HCC.
Phase: PHASE2 • Sponsor: Raymond Chung • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a new pill ease borderline personality disorder symptoms?
Symptom relief CompletedThe primary objective of the proposed study is to evaluate the safety and efficacy of Caplyta (lumateperone) in adults with borderline personality disorder (BPD). Sixty subjects with BPD will be randomized in a 1:1 fashion to either Caplyta (42mg/day) or matching placebo for 8 we…
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Virtual diabetes coaching could ease daily burden for type 1 patients
Disease control Recruiting nowOVERVIEW: People living with type 1 diabetes (T1D) are expected to fit self-management and regular clinical consultations into busy lives. T1D self-management programs that offer frequent contact with care teams are most effective in helping patients achieve optimal glycemic cont…
Phase: NA • Sponsor: Unity Health Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo tackles tough melanoma
Disease control OngoingThis phase II clinical trial tests how well rigosertib plus pembrolizumab workings in treating patients with melanoma which cannot be removed by surgery (unresectable) or that has spread from where it first started (primary site) to other places in the body (metastatic), and that…
Phase: PHASE2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Sniffing out Alzheimer's: simple smell test could spot early brain changes
Diagnosis Recruiting nowThe goal of this study is to objectively test one's sense of smell, called olfaction, in participants with Subjective Cognitive Concerns (SCC), Mild Cognitive Impairment, Mild Behavioral Impairment (MBI), and age-matched controls. The main question it aims to answer is whether th…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New drug combo for liver cancer passes safety check in 1,200 patients
Disease control CompletedThis investigation will be conducted to collect information of safety in patients with unresectable hepatocellular carcinoma (HCC) treated with the combination therapy of IMJUDO 25 mg, 300 mg and IMFINZI Intravenous Infusion 120 mg, 500 mg or with IMFINZI monotherapy under actual…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New daily pill could simplify tough bone infection treatment
Disease control OngoingThe study design is a randomized, open-label, clinical trial of omadacycline vs Standard of Care (SOC) antibiotics for bone and join infection (BJI) treatment. Study participants will have their BJI regimen chosen by their treating physicians, (typically Infectious Diseases for h…
Phase: PHASE2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New scan could spot hidden cancer spread in head and neck patients
Diagnosis Recruiting nowThe goal of this phase I clinical trial is to evaluate the usefulness of an imaging test (zirconium Zr89 panitumumab \[89Zr panitumumab\]) with positron emission tomography (PET)/computed tomography (CT) for diagnosing the spread of disease from where it first started (primary si…
Phase: PHASE1 • Sponsor: Eben Rosenthal • Aim: Diagnosis
Last updated Jun 27, 2026 12:31 UTC
-
Sound waves to the brain: a new hope for Treatment-Resistant depression?
Symptom relief Recruiting nowThe primary objective of this study is to optimize the protocol for the TUS administration in patients with TRD while gaining an initial impression of treatment efficacy.
Phase: NA • Sponsor: Centre Hospitalier St Anne • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Diet and exercise combo may boost muscle in heart failure patients
Disease control Recruiting nowHeart failure with reduced ejection fraction (HFrEF) is frequently associated with abnormalities in body composition, including reduced skeletal muscle mass and sarcopenia, which are independent predictors of reduced exercise tolerance, impaired quality of life, and increased mor…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC